RXG is leading a paradigm shift by building a dedicated cell therapy ecosystem comprising of CAR-T clinical teams, an inpatient cell therapy center and an outpatient infusion center (distribution network). Each of these features is necessary to provide safe access to CAR-T. Our strategy is explicitly designed to provide value to all key stakeholders: patients, payers, hospitals and cellular therapy companies.